Taysha Gene Therapies (TSHA) Prepaid Assets (2020 - 2026)

Taysha Gene Therapies has reported Prepaid Assets for 7 years, with the latest figure at $1.0 million in Q1 2026.

• Quarterly Prepaid Assets rose 335.78% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 335.78% YoY) and the FY2025 annual result came in at $4.4 million, up 67.52% from the prior year.
• Prepaid Assets slipped to $1.0 million in Q1 2026 per TSHA's latest filing, from $4.4 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $4.4 million in Q4 2025 and troughed at $74000.0 in Q3 2022.
• A 5-year average of $930470.6 and a median of $404000.0 in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2025: Prepaid Assets slumped 98.91% in 2022, then surged 1750.91% in 2025.
• Over 5 years, Prepaid Assets stood at $388000.0 in 2022, then slipped by 24.74% to $292000.0 in 2023, then surged by 805.82% to $2.6 million in 2024, then soared by 67.52% to $4.4 million in 2025, then tumbled by 77.18% to $1.0 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $1.0 million, $4.4 million, and $456000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.